US regulators approved updated versions of the Covid-19 vaccines made by Pfizer Inc. and Moderna Inc. as infections climb across the country.
The vaccines, which will target the currently circulating variant called KP.2, were approved by the US Food and Drug Administration for use by people 12 years old and up. The vaccines also have emergency authorization for use in children 6 months through 11 years old.